Metraipolis › archive › dc_be94dceab87a

Rifampicin and ofloxacin dual therapy as an adjunct to standard MB-MDT in the management of nodulo-ulcerative lepromatous leprosy with histoid-like features:… — Europe PMC PMID:40927195

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40927195
DOI
10.3389/fmed.2025.1596617
License (as archived)
solo-consultazione
Archived
2026-11-10T09:39:02.469Z
SHA-256 of the archived text
5d11a66a38d3ef3733f98396e84447f7e25185c5bbbe1da5f29b0c8f206f892e
Stable URL of this page
https://metraipolis.com/documento/dc_be94dceab87a

How to cite

Rifampicin and ofloxacin dual therapy as an adjunct to standard MB-MDT in the management of nodulo-ulcerative lepromatous leprosy with histoid-like features:… — Europe PMC PMID:40927195 — Europe PMC (en), https://europepmc.org/article/MED/40927195 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_be94dceab87a (Metraipolis archive dc_be94dceab87a, sha256 5d11a66a38d3ef3733f98396e84447f7e25185c5bbbe1da5f29b0c8f206f892e)
BibTeX
@misc{dcbe94dceab87a,
  title = {Rifampicin and ofloxacin dual therapy as an adjunct to standard MB-MDT in the management of nodulo-ulcerative lepromatous leprosy with histoid-like features:… — Europe PMC PMID:40927195},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40927195},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_be94dceab87a; sha256 5d11a66a38d3ef3733f98396e84447f7e25185c5bbbe1da5f29b0c8f206f892e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40927195. Agents can read the archived copy with the MCP tool read_document.